© Copyright Nostre Net
Market Overview:
Glaucoma is an eye disorder that causes damage to the optic
nerve if left untreated, leading to the permanent loss of vision. As per the
report that has been published by Market research Future (MRFR), the global
glaucoma surgery market is registered to expand at a noteworthy CAGR of 7.9%
during the forecast period of 2017-2023.
Market Drivers and Restraints:
Glaucoma is considered to be one of the leading causes of
preventable blindness. With the rise in geriatric population, the incidences of
glaucoma are increasing resulting in the high demand for surgical treatments,
which in turn is fueling the growth of the global glaucoma surgery market.
Increasing inclination towards permanent and faster cure
through surgery over long-term use of medication is one of the major drivers of
the global glaucoma
surgery market size. In addition, rise in prevalence of causative disorders
such as diabetes and ocular hypertension are inducing need for surgical
treatments, leading to the expansion of the global glaucoma surgery
market.
However, lack of awareness, preference of non-invasive
treatments and high cost associated with the treatment are likely to create
hindrance in the growth of the global glaucoma surgery market during the
forecast period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1342
Key Players:
The leading players profiled by MRFR in the report on the
global glaucoma surgery market are Novartis AG (Switzerland), Allergan (the
U.S.), Merck & Co., Inc. (the U.S.), Abbott (the U.S.), Akorn, Inc. (the
U.S.), Teva Pharmaceuticals (the U.S.), Bausch & Lomb (the U.S.), Pfizer,
Santen (Japan), Carl Zeiss Meditec (Germany), Alcon (the U.S.), Ellex
Medical Lasers (Australia), Lumenis (the U.S.), Topcon Medical Systems (the
U.S.), Nidek (the U.S.), OPHTEC (the U.S.), Optos (the U.S.), Accutome (the
U.S.), AqueSys (Taiwan), Canon (Japan), Essilor (France) and Iridex
Corporation (the U.S.)
Market Segmentation:
The global glaucoma surgery market has been segmented on the
basis of target, surgery and end-user. Based on target, the glaucoma surgery
market is segmented into trabecular meshwork, suprachoroidal space and others.
Based on surgery, the glaucoma surgery market is segmented into angle closure
glaucoma surgery, aqueous shunt surgery, laser surgery and others. Based on end
users, the glaucoma surgery market is segmented into hospital, ambulatory
surgery centers and others.
Regional Analysis:
The global glaucoma surgery market is geographically
segmented into four major regions such as North America, Asia Pacific, Europe
and the Middle East and Africa. The North America region is leading the global
glaucoma surgery market with respect to market size. The high number of
population suffering from diabetes and other eye disorder and increasing
healthcare expenditure are some of the major factors that are fueling the
growth of the glaucoma surgery market in this region. The Europe region is
registered to be the second largest market for glaucoma surgery owing to the increased
research and development for introduction of advanced surgical devices in this
region. The Asia Pacific region is projecting significant growth in the global
glaucoma surgery market owing to the large population base and increasing
prevalence of glaucoma in this region.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/glaucoma-surgery-market-1342
Ventilator
associated pneumonia Market
The Wall